The Impact of a Genomic Assay on Urologist Treatment Preference in Active Surveillance-Eligible Men
Sponsor/Host: Institute for Public Health and Medicine (IPHAM)
Location: Hybrid: via Zoom & Hughes Auditorium, Lurie Medical Research Building
Address: 303 E. Superior, Chicago, IL 60611
More information: View Event Page »
Dr. Adam Murphy will summarize the results of a randomized controlled trial assessing the impact of a Genomic Assay on urologists and patients treatment preferences for favorable risk. prostate cancer.
This seminar is offered as a HYBRID event: join us IN-PERSON or ONLINE. Please RSVP regardless and indicate your intended mode. The in-person event will be held in Hughes Auditorium of the Lurie Medical Research Building at 303 E. Superior, Chicago. Lunch will be provided for in person attendees and will be available on a first-come, first-served basis.